GOLIKE Shake & Drink Makes the Intake of the Amino Acid Mix as Easy as Drinking a Glass of Water - Seite 2

People living with PKU can now choose whether to continue adding PKU GOLIKE to their favourite meals or use the GOLIKE Shake & Drink bottle, offered for free with every pack of PKU GOLIKE, to drink the mix like a glass of water, or to alternate the two methods of consumption.

About Phenylketonuria or PKU

Phenylketonuria or PKU is a rare, recessive metabolic genetic disorder that affects about 500,000 people all over the world. PKU is characterized by a deficiency or lack of an enzyme needed to metabolize phenylalanine (Phe). PKU is treated by means of a strict diet – to be followed for life – with a low phenylalanine content (and thus a low protein content), which therefore requires amino acid supplementation through specific products.  

About PKU GOLIKE

PKU GOLIKE is a phenylalanine-free food for special medical purposes (FSMP) in granules, containing amino acids, minerals, vitamins and other nutrients. Engineered with the Physiomimic Technology, PKU GOLIKE is characterised by a special coating that ensures a more physiological absorption of the amino acids, masking their unpleasant taste, odour and aftertaste. For further details, see: www.apr.ch/apr-pharma-products/medical-prescription/genetic-metabolic-disease/ 

About APR Applied Pharma Research s.a.

APR is an independent pharma company headquartered in Switzerland with subsidiaries in Italy and Germany focused, since more than 25 years, in the development and commercialisation of products intended to improve the quality of life of patients and families affected with rare or debilitating diseases.

APR leverages many years of experience in developing patented drug delivery technologies, which are then applied to develop innovative therapeutic solutions.

APR's portfolio includes products for the treatment of rare or niche diseases which are commercialised in about 50 countries worldwide either directly through its subsidiaries as well as indirectly through distribution agreements with selected partners. APR believes that a tireless effort in the research represents the fundamental pillar of the future therapeutic solutions and, for this reason, the pipeline includes products at different stage of development concentrated in 3 selected therapeutic areas: inherited metabolic recessive diseases, cancer supportive care and skin rare diseases.

Logo - https://mma.prnewswire.com/media/1194581/APR_Applied_Pharma_Research_Logo.jpg
Photo - https://mma.prnewswire.com/media/1194582/GOLIKE_Shake__Drink.jpg

Contact:
APR Applied Pharma Research s.a.
GOLIKE Team
[e-mail]
[phone]